Author

K. Blom

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Assay:flow cytometry· 1

Frequent Co-Authors

G. Ahlen· 2 shared H.-G. Ljunggren· 2 shared J. Klingström· 2 shared J. T. Sandberg· 2 shared K. T. Maleki· 2 shared L. Frelin· 2 shared M. Garcia· 2 shared M. Sällberg· 2 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

G. Ahlen

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster

U. Marking, O. Bladh, K. Aguilera, Y. Yang, N. Greilert-Norin, K. Blom, S. Hober, J. Klingstrom, S. Havervall, M. Aberg, D. J. Sheward, C. Thalin

This study shows that a monovalent XBB.1.5-adapted BNT162b2 booster vaccine enhances binding and neutralizing antibodies against XBB.1.5 and BA.2.86 in elderly individuals with prior vaccinations.

bioRxiv · Dec 21, 2023 · PreprintImmunology

Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infection

J. T. Sandberg, R. Varnaite, W. Christ, P. Chen, J. R. Muvva, K. T. Maleki, M. Garcia, M. Dzidic, E. Folkesson, M. Skagerberg, G. Ahlen, L. Frelin, M. Sällberg, The Karolinska COVID-19 Study Group, L. I. Eriksson, , S. Gredmark-Russ

This study tracks immune responses in hospitalized COVID-19 patients up to 9 months post-infection, showing persistent neutralizing antibodies and memory B and T cells.

bioRxiv · Mar 17, 2021 · PreprintImmunology

Expansion of SARS-CoV-2-specific Antibody-secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients

R. Varnaite, M. Garcia, H. Glans, K. T. Maleki, J. T. Sandberg, J. Tynell, W. Christ, N. Lagerqvist, H. Asgeirsson, H.-G. Ljunggren, G. Ahlen, L. Frelin, M. Sällberg, K. Blom, J. Klingström, S. Gredmark-Russ

This study examines B cell and antibody responses in hospitalized COVID-19 patients, finding expanded SARS-CoV-2-specific antibody-secreting cells and neutralizing antibodies.

bioRxiv · May 28, 2020Immunology

Clonally distinct differentiation trajectories shape CD8+ memory T cell heterogeneity after acute viral infections in humans

J. E. Mold, L. Modolo, J. Hard, M. Zamboni, A. J. M. Larsson, C.-J. Eriksson, P. Stahl, E. Borgstrom, S. Picelli, B. Reinius, R. Sandberg, P. Reu, C. Talavera-Lopez, B. Andersson, K. Blom, , J. Frisen

The paper tracks CD8+ T cell clones after yellow fever vaccination, showing clonal selection and biased differentiation trajectories shaping memory T cell heterogeneity.

bioRxiv · Nov 8, 2019 · PreprintImmunology